1. Usual opioid dosing does not adversely affect the course of healthcare-associated Clostridioides difficile infection
- Author
-
Shailendra Singh, Ashley Huggett, Muhammad Kawsara, Monica Chowdhry, Brittain McJunkin, Douglas Haden, Ahmad Khan, Mustafa Bhaty, Suzanne Kemper, Kristen Helmick, Muhammad Shah, Andrea Stark, and Junaid Farooq
- Subjects
medicine.medical_specialty ,genetic structures ,business.industry ,musculoskeletal, neural, and ocular physiology ,macromolecular substances ,General Medicine ,Affect (psychology) ,Reduced model ,03 medical and health sciences ,0302 clinical medicine ,nervous system ,Opioid ,Healthcare associated ,Internal medicine ,Medicine ,030211 gastroenterology & hepatology ,In patient ,030212 general & internal medicine ,Dosing ,Risk factor ,business ,Clostridioides ,medicine.drug - Abstract
Aim: We sought to determine if opioid exposure may have a detrimental effect on the course of Clostridioides difficile infection (CDI). Materials & methods: We compared opioid exposure in patients with well-defined severe CDI and non-severe CDI. Results: Following exclusions, 403 records were reviewed. Of this group, 128/403 (31.7%) were determined to have severe CDI by strict criteria, and 275/403 (68.3%) were found to have non-severe CDI. Full multivariate regression and reduced model of potential predictors for severe CDI showed no association with opioids prescribed. Conclusion: Opioid exposure (predominantly in modest range) does not appear to be a risk factor for severe healthcare-associated CDI.
- Published
- 2021
- Full Text
- View/download PDF